Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04326010 · ClinicalTrials.gov registry record
Prospective Clinical Follow-up of the Echo Bi-Metric Microplasty Stem for Total Hip Arthroplasty
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 206
- Enrollment target
NCT04326010 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 206 participants.
The verdict
NCT04326010 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 206 participants
- Enrollment target
Study Summary
The primary objective of this study is to characterize survivorship of the Echo Bi-Metric Microplasty stem in unilateral or bilateral primary total hip arthroplasty at 5 years postoperative.
Interventions
- DEVICE Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2017-02-20 |
| Est. Completion | 2024-12-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04326010
The ClinicalTrials.gov registry entry for NCT04326010 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Surgery is the first listed.
NCT04326010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04326010 about?
NCT04326010 is a clinical study titled "Prospective Clinical Follow-up of the Echo Bi-Metric Microplasty Stem for Total Hip Arthroplasty". The primary objective of this study is to characterize survivorship of the Echo Bi-Metric Microplasty stem in unilateral or bilateral primary total hip arthroplasty at 5 years postoperative.
What is the current status of trial NCT04326010?
This trial is currently terminated. The enrollment target is 206 participants. The study started on 2017-02-20. Estimated completion is 2024-12-04.
What interventions are being tested in trial NCT04326010?
The interventions under investigation include: Surgery (DEVICE).
Who is sponsoring clinical trial NCT04326010?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.